The Wine & Spirits Wholesalers of America (WSWA) sent a letter to Congress offering advice on regulating hemp-derived cannabinoids, including CBD and delta-8 THC.
The WSWA, which published a letter in April urging Congress to legalize and regulate cannabis like alcohol, noted in this recent letter that the alcohol industry has experience in regulating intoxicating products and can help Congress develop a safe and consumer-centric regulatory framework for hemp-derived cannabinoids, reported Marijuana Moment.
In the letter to the House and Senate committees, the WSWA recommended that Congress create a distinct regulatory category for intoxicating cannabinoids like delta-8 THC and that the Alcohol and Tobacco Tax and Trade Bureau (TTB) be responsible for overseeing those products.
“The transition from Prohibition to legal status for alcohol has been an American success story,” the letter says. “Since the 21st Amendment’s enactment, a safe, consumer-centric and economically vibrant marketplace has developed, one serving the needs of both regulators and consumers. While individual regulations have evolved, the basic federal regulatory structure of permitting and tax collection continues to endure.”
The WSWA also noted that Congress should ensure that states are seen as regulatory partners and that consumer protections are promoted.
The association's comments come as Congress is considering creating a framework to oversee the nation's cannabis market. The Food and Drug Administration has said that it currently lacks the necessary authority to enact a regulatory framework for CBD on its own.
Some advocates see the alcohol association's engagement on the issue as a boon to reform efforts, while others have been skeptical about the alcohol industry's influence on cannabis legalization legislation.
Want to talk more about this important topic and many more cannabis-related issues?
Join us at the upcoming Benzinga Cannabis Capital Conference. Mark your calendars for September 27-28 in Chicago. Get your tickets before prices go up.
All information is available on bzcannabis.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.